Serum PCSK9 did not demonstrate a correlation with fecal calprotectin and C-reactive protein (CRP) in IBD patients in the entire cohort, in both male and female patients (Tables S1 and 2). This evidence concerns the gene PCSK9 and inflammatory bowel disease.